ALXO
Price
$1.52
Change
-$0.02 (-1.30%)
Updated
Dec 11 closing price
Capitalization
82.41M
83 days until earnings call
Intraday BUY SELL Signals
ATXS
Price
$12.92
Change
+$0.01 (+0.08%)
Updated
Dec 12, 04:59 PM (EDT)
Capitalization
736.97M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALXO vs ATXS

Header iconALXO vs ATXS Comparison
Open Charts ALXO vs ATXSBanner chart's image
ALX Oncology Holdings
Price$1.52
Change-$0.02 (-1.30%)
Volume$85.63K
Capitalization82.41M
Astria Therapeutics
Price$12.92
Change+$0.01 (+0.08%)
Volume$5.26K
Capitalization736.97M
ALXO vs ATXS Comparison Chart in %
ALXO
Daily Signal:
Gain/Loss:
ATXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALXO vs. ATXS commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and ATXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ALXO: $1.52 vs. ATXS: $12.91)
Brand notoriety: ALXO and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALXO: 24% vs. ATXS: 42%
Market capitalization -- ALXO: $82.41M vs. ATXS: $736.97M
ALXO [@Biotechnology] is valued at $82.41M. ATXS’s [@Biotechnology] market capitalization is $736.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALXO and ATXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 5 TA indicator(s) are bullish while ATXS’s TA Score has 3 bullish TA indicator(s).

  • ALXO’s TA Score: 5 bullish, 5 bearish.
  • ATXS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALXO is a better buy in the short-term than ATXS.

Price Growth

ALXO (@Biotechnology) experienced а +10.95% price change this week, while ATXS (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

ALXO is expected to report earnings on Mar 05, 2026.

ATXS is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($737M) has a higher market cap than ALXO($82.4M). ATXS YTD gains are higher at: 44.407 vs. ALXO (-8.982). ALXO has higher annual earnings (EBITDA): -114.05M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. ALXO (79.3M). ATXS has less debt than ALXO: ATXS (4.77M) vs ALXO (10M). ALXO (0) and ATXS (0) have equivalent revenues.
ALXOATXSALXO / ATXS
Capitalization82.4M737M11%
EBITDA-114.05M-131.42M87%
Gain YTD-8.98244.407-20%
P/E RatioN/AN/A-
Revenue00-
Total Cash79.3M259M31%
Total Debt10M4.77M210%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALXOATXS
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALXO
Daily Signal:
Gain/Loss:
ATXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LISMF0.320.01
+3.05%
Lithium South Dev Corp.
AOCIF15.64N/A
N/A
Autocanada Inc
NCTKF25.06N/A
N/A
Nabtesco Corp.
SNNUF14.55N/A
N/A
Smith & Nephew PLC
TAPM0.28N/A
N/A
Tapinator, Inc.

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
-1.30%
MDGL - ALXO
56%
Loosely correlated
+3.41%
AXON - ALXO
45%
Loosely correlated
+2.22%
AMRN - ALXO
43%
Loosely correlated
+1.61%
ALNY - ALXO
39%
Loosely correlated
+2.02%
VERA - ALXO
36%
Loosely correlated
+3.79%
More